查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572080

阿斯匹灵市场：按产品、包装、剂型、剂量、分销管道和最终用户 - 2025-2030 年全球预测

Aspirin Market by Product (Buffered Aspirin, Enteric-Coated Aspirin, Regular Aspirin), Packaging (Blister Packs, Bottles, Sachets), Dosage Form, Dosage, Distribution Channel, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年阿斯匹灵市场价值为24.9亿美元，预计到2024年将达到25.8亿美元，复合年增长率为4.62%，预计到2030年将达到34.2亿美元。

阿斯匹灵是一种广泛使用的药物，以其镇痛、发炎和解热特性而闻名，是全世界非处方药和处方药的主要成分。它的需求主要是因为它在疼痛管理、退烧和预防心血管事件方面的功效，这已经巩固了它在现代医学中的地位。该药物可应用于各种最终用户，包括用于疼痛管理的个人消费者、用于术后护理的医疗机构以及用于关节炎和心血管保护等慢性疾病的长期医疗保健管理。阿斯匹灵市场的成长受到心血管疾病盛行率增加、老年人口成长以及对疼痛管理解决方案的持续需求等因素的显着影响。此外，消费者对阿斯匹灵预防保健功效的认识不断增强，也支持了其广泛使用。然而，它们受到长期使用相关的严重副作用的限制，包括胃肠道併发症，这可能会阻碍它们的广泛使用。监管挑战和替代疗法的可用性也构成了重大挑战。开发更安全的製剂（例如缓衝阿斯匹灵）以及探索阿斯匹灵在癌症预防等新治疗领域的潜在作用存在机会。投资研发以探索阿斯匹灵的潜力并提高其安全性可提供显着的竞争优势。该市场竞争激烈，拥有众多学名药厂商，因此透过创新和有针对性的行销策略实现差异化至关重要。鼓励市场相关人员专注于策略伙伴关係和联盟，以加强分销网络，并参与教育消费者安全使用的宣传活动。咀嚼片和缓释片等剂型和给药方法的创新表明了潜在的​​成长途径，而对阿斯匹灵广泛健康用途的持续研究可能会开闢新的、利润丰厚的市场。

主要市场统计
基准年[2023] 24.9亿美元
预测年份 [2024] 25.8亿美元
预测年份 [2030] 34.2亿美元
复合年增长率（%） 4.62%

市场动态：揭示快速发展的阿斯匹灵市场的关键市场洞察

阿斯匹灵市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 心血管疾病盛行率增加
    • 扩大阿斯匹灵在癌症预防和发炎疾病治疗的应用
    • 人口老化加剧，更容易罹患慢性病
  • 市场限制因素
    • 提供疗效更好、副作用更少的替代药物
  • 市场机会
    • 研发投资改良阿斯匹灵配方
    • 线上平台和远端医疗快速成长
  • 市场挑战
    • 阿斯匹灵新配方和用途核准的严格监管要求

波特五力：驾驭阿斯匹灵市场的策略工具

波特的五力架构是了解阿斯匹灵市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解阿斯匹灵市场的外部影响

外部宏观环境因素在塑造阿斯匹灵市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解阿斯匹灵市场的竞争状况

阿斯匹灵市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵阿斯匹灵市场供应商的绩效评估

FPNV定位矩阵是评估阿斯匹灵市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划阿斯匹灵市场的成功之路

阿斯匹灵市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病盛行率增加
      • 扩大阿斯匹灵在癌症预防和发炎疾病治疗的应用
      • 人口老化加剧，更容易罹患慢性病
    • 抑制因素
      • 提供疗效更好、副作用更少的替代药物
    • 机会
      • 投资阿斯匹灵强化配方的研发
      • 线上平台和远端医疗快速成长
    • 任务
      • 阿斯匹灵新配方和用途核准的严格监管要求
  • 市场区隔分析
    • 产品：镇痛和发炎特性增加了阿斯匹灵的常规使用
    • 最终用户：阿斯匹灵的广泛使用导致其在诊所的使用不断增加。
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章阿斯匹灵市场：副产品

  • 缓衝阿斯匹灵
  • 肠溶阿斯匹林
  • 普通阿斯匹林

第七章阿斯匹灵市场：依包装分类

  • 泡壳包装
  • 瓶子
  • 小袋

第八章阿斯匹灵市场：按剂型

  • 胶囊
  • 凝胶
  • 粉末
  • 药片

第 9 章 阿斯匹灵市场：按剂量

  • 高剂量
  • 低剂量
  • 中等剂量

第10章阿斯匹灵市场：依通路划分

  • 医院药房
  • 网路药房
  • 零售药房

第十一章阿斯匹灵市场：依最终用户分类

  • 诊所
  • 居家护理
  • 医院
  • 製药公司
  • 调查机构

第十二章美洲阿斯匹灵市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太阿斯匹灵市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章 欧洲、中东和非洲阿斯匹灵市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • PEARLS 试验由比尔及梅琳达盖兹基金会资助，正在与世界各地的机构合作，并使用人工智慧工具来研究预防妊娠毒血症的最佳阿斯匹灵剂量。
  • 战略分析和建议
Product Code: MRR-976C0ED91C3C

The Aspirin Market was valued at USD 2.49 billion in 2023, expected to reach USD 2.58 billion in 2024, and is projected to grow at a CAGR of 4.62%, to USD 3.42 billion by 2030.

Aspirin, a widely used pharmaceutical agent known for its analgesic, anti-inflammatory, and antipyretic properties, is a staple in both over-the-counter and prescription medications globally. Its necessity primarily stems from its efficacy in managing pain, reducing fever, and preventing cardiovascular events, which has cemented its place in modern medicine. This drug finds applications across a diverse range of end-users, including individual consumers for pain management, healthcare facilities for post-operative care, and long-term healthcare management for chronic conditions like arthritis and cardiovascular protection. The aspirin market's growth is heavily influenced by factors such as increasing prevalence of cardiovascular diseases, rising geriatric population, and the ongoing demand for pain management solutions. Additionally, growing consumer awareness about the preventive healthcare benefits of aspirin fuels its adoption. However, the market faces limitations due to the serious side effects associated with long-term use, including gastrointestinal complications, which may hinder widespread usage. Regulatory challenges and the availability of alternative therapies also pose significant challenges. Opportunities lie in the development of safer formulations, such as buffered aspirin, and the exploration of aspirin's potential role in emerging therapeutic areas like cancer prevention. Investment in R&D to explore aspirin's full potential and improve safety profiles can offer significant competitive advantages. As the market is highly competitive with numerous generic players, differentiation through innovation and targeted marketing strategies is crucial. Market players are recommended to focus on strategic partnerships and collaborations to enhance their distribution networks and engage in awareness campaigns to educate consumers about safe usage. Innovation in dosage forms and delivery methods, like chewables or sustained-release tablets, presents potential growth avenues, while ongoing research into aspirin's broader health applications could reveal new, lucrative markets.

KEY MARKET STATISTICS
Base Year [2023] USD 2.49 billion
Estimated Year [2024] USD 2.58 billion
Forecast Year [2030] USD 3.42 billion
CAGR (%) 4.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aspirin Market

The Aspirin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiovascular diseases
    • Expanding applications of aspirin for cancer prevention and treatment of inflammatory conditions
    • Rise in aging population susceptible to chronic diseases
  • Market Restraints
    • Availability of Alternative Medications with improved efficacy and fewer side effects
  • Market Opportunities
    • Investment in R&D for enhanced formulations of aspirin
    • Burgeoning growth in online platforms and telemedicine
  • Market Challenges
    • Stringent regulatory requirements for the approval of new formulations and applications of aspirin

Porter's Five Forces: A Strategic Tool for Navigating the Aspirin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aspirin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aspirin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aspirin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aspirin Market

A detailed market share analysis in the Aspirin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aspirin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aspirin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aspirin Market

A strategic analysis of the Aspirin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aspirin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Anhui Chemical Group Co., Ltd., Bayer AG, Bristol-Myers Squibb Company, China Meheco Topfond Pharma Co., Ltd., Cigna Corporation, Divi's Laboratories Limited, Dow Chemical Company, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline PLC, Globe Quimica S.A., Granules India Limited, Hebei Jiheng (Group) Pharmaceutical Co., Ltd., Hubei Biocause Heilen Pharmaceutical Co., Ltd., Jiangsu Nanjing Huaxing Chemical Co., Ltd., Jiangsu Pioneer Pharma Co., Ltd., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Mylan N.V., Nanjing Well Pharmaceutical Technology Co., Ltd., Pfizer Inc., Sanofi S.A., SEQENS SAS, Shandong Xinhua Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., and Zhenjiang Gaopeng Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Aspirin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Buffered Aspirin, Enteric-Coated Aspirin, and Regular Aspirin.
  • Based on Packaging, market is studied across Blister Packs, Bottles, and Sachets.
  • Based on Dosage Form, market is studied across Capsules, Gels, Powders, and Tablets.
  • Based on Dosage, market is studied across High-Dose, Low-Dose, and Medium-Dose.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on End Users, market is studied across Clinics, Home Care, Hospitals, Pharmaceutical Companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular diseases
      • 5.1.1.2. Expanding applications of aspirin for cancer prevention and treatment of inflammatory conditions
      • 5.1.1.3. Rise in aging population susceptible to chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of Alternative Medications with improved efficacy and fewer side effects
    • 5.1.3. Opportunities
      • 5.1.3.1. Investment in R&D for enhanced formulations of aspirin
      • 5.1.3.2. Burgeoning growth in online platforms and telemedicine
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for the approval of new formulations and applications of aspirin
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing utilization of regular aspirin owing to its pain-relieving and anti-inflammatory properties
    • 5.2.2. End Users: Evolving utilization of aspirin across the clinics owing to its broad availability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aspirin Market, by Product

  • 6.1. Introduction
  • 6.2. Buffered Aspirin
  • 6.3. Enteric-Coated Aspirin
  • 6.4. Regular Aspirin

7. Aspirin Market, by Packaging

  • 7.1. Introduction
  • 7.2. Blister Packs
  • 7.3. Bottles
  • 7.4. Sachets

8. Aspirin Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Capsules
  • 8.3. Gels
  • 8.4. Powders
  • 8.5. Tablets

9. Aspirin Market, by Dosage

  • 9.1. Introduction
  • 9.2. High-Dose
  • 9.3. Low-Dose
  • 9.4. Medium-Dose

10. Aspirin Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies

11. Aspirin Market, by End Users

  • 11.1. Introduction
  • 11.2. Clinics
  • 11.3. Home Care
  • 11.4. Hospitals
  • 11.5. Pharmaceutical Companies
  • 11.6. Research Institutes

12. Americas Aspirin Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Aspirin Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Aspirin Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. PEARLS trial, funded by Bill and Melinda Gates Foundation, explores optimal aspirin doses to prevent pre-eclampsia, collaborating with global institutions and utilizing AI tools
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Anhui Chemical Group Co., Ltd.
  • 3. Bayer AG
  • 4. Bristol-Myers Squibb Company
  • 5. China Meheco Topfond Pharma Co., Ltd.
  • 6. Cigna Corporation
  • 7. Divi's Laboratories Limited
  • 8. Dow Chemical Company
  • 9. Dr. Reddy's Laboratories Ltd.
  • 10. GlaxoSmithKline PLC
  • 11. Globe Quimica S.A.
  • 12. Granules India Limited
  • 13. Hebei Jiheng (Group) Pharmaceutical Co., Ltd.
  • 14. Hubei Biocause Heilen Pharmaceutical Co., Ltd.
  • 15. Jiangsu Nanjing Huaxing Chemical Co., Ltd.
  • 16. Jiangsu Pioneer Pharma Co., Ltd.
  • 17. Lupin Pharmaceuticals, Inc.
  • 18. Merck & Co., Inc.
  • 19. Mylan N.V.
  • 20. Nanjing Well Pharmaceutical Technology Co., Ltd.
  • 21. Pfizer Inc.
  • 22. Sanofi S.A.
  • 23. SEQENS SAS
  • 24. Shandong Xinhua Pharmaceutical Co., Ltd.
  • 25. Sun Pharmaceutical Industries Ltd.
  • 26. Taj Pharmaceuticals Ltd.
  • 27. Zhenjiang Gaopeng Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ASPIRIN MARKET RESEARCH PROCESS
  • FIGURE 2. ASPIRIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ASPIRIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ASPIRIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ASPIRIN MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ASPIRIN MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ASPIRIN MARKET SIZE, BY PACKAGING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ASPIRIN MARKET SIZE, BY PACKAGING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ASPIRIN MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ASPIRIN MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ASPIRIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES ASPIRIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ASPIRIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. ASPIRIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ASPIRIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ASPIRIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ASPIRIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ASPIRIN MARKET DYNAMICS
  • TABLE 7. GLOBAL ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ASPIRIN MARKET SIZE, BY BUFFERED ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ASPIRIN MARKET SIZE, BY ENTERIC-COATED ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ASPIRIN MARKET SIZE, BY REGULAR ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ASPIRIN MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ASPIRIN MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ASPIRIN MARKET SIZE, BY SACHETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ASPIRIN MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ASPIRIN MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ASPIRIN MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ASPIRIN MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ASPIRIN MARKET SIZE, BY HIGH-DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ASPIRIN MARKET SIZE, BY LOW-DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ASPIRIN MARKET SIZE, BY MEDIUM-DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ASPIRIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ASPIRIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ASPIRIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ASPIRIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ASPIRIN MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ASPIRIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ASPIRIN MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ASPIRIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ASPIRIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 284. ASPIRIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. ASPIRIN MARKET, FPNV POSITIONING MATRIX, 2023